Supporting Patients With Diabetic Eye Disease

Diabetic eye disease, most commonly presenting as diabetic retinopathy, is the leading cause of preventable blindness worldwide. The pathogenesis of diabetic eye disease involves complex biochemical pathways that are set in motion by chronic hyperglycemia. Primary treatment options for diabetic retinopathy include laser photocoagulation and intravitreal injection of antivascular endothelial growth factor agents. Treatments aim to stabilize or improve visual function, but significant vision loss can still occur. Pharmacists play a vital role in supporting patients with the disease.